Beyond A1C: Smarter Assessment Strategies for Insulin Resistance
Beyond A1C: Smarter Assessment Strategies for Insulin Resistance
Insulin Resistance Webinar Series, Part 2 • Featuring Dr. Pushpa Larsen, ND • Meridian Valley Lab
Early detection of insulin resistance is key to effective intervention—but common tests like fasting glucose and A1C often fail to catch it in time. In this clinician-focused webinar, Dr. Pushpa Larsen shares more precise tools for assessment and monitoring that go beyond standard labs.
“We’re aiming for prevention, not just diagnosis,” Dr. Larsen emphasizes.
Watch the Webinar
Show Video
Revisiting the Basics: Why the Current Model Isn’t Enough
Show Section
Most primary care workflows rely on glucose-centric metrics. But Dr. Larsen and Meridian Valley Lab challenge this status quo by exploring insulin levels directly. Unlike glucose, which can stay “normal” for years, insulin elevations often precede diabetes by a decade or more.
The Fingerstick GTIR Test: Practical, Powerful, Patient-Friendly
Show Section
The test highlighted in this webinar is the Glucose Tolerance Insulin Response (GTIR) panel offered by Meridian Valley Lab. It uses dried blood spot collection and measures both glucose and insulin over a set period. This offers:
- Clear detection of Kraft Patterns
- Better personalization of lifestyle or pharmaceutical interventions
- An easy in-office or at-home collection method
Clinical Implementation: Case Examples and Protocols
Show Section
Dr. Larsen walks through how to interpret test results, what patterns to look for, and how clinicians can use these insights for early intervention. She explains:
- How to spot silent insulin resistance even with normal A1C
- Which patient populations benefit most from GTIR screening
- How to track improvements over time
Continue the Insulin Resistance Webinar Series
Show Links
Order or Learn More
Show CTA
Practitioners: If you’d like to incorporate GTIR screening into early detection or monitoring workflows, contact Client Services to request a kit or discuss clinical fit.
Patients: Ask your licensed provider whether insulin resistance screening beyond A1C is appropriate for your symptoms and prevention goals. Meridian Valley Lab provides laboratory services only and cannot advise patients directly.
Call: 855.405.8378 | 206.209.4200
References
Show References
If you’d like a citation list supporting the concepts discussed in this webinar (Kraft patterns, early insulin elevation, and clinical monitoring), please contact our team.
